RxDoctor Payments Data

Eshamumerene Esin, MD

Family Medicine · Marietta, GANPI 1538459292

Payments from drug & device makers

$3,464in general payments, 2019–2025

Across 204 payments — averaging $16.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$800
  • Lilly USA, LLC$409
  • Pfizer$282
  • AstraZeneca$264
  • AbbVie$185
  • Amgen$184
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$3,464100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,464 in reported general payments places this provider in the 75th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$48,069
Medicare patients
165
Services billed
516

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin42$55,831
MounjaroTirzepatide33$48,034
OzempicSemaglutide21$27,837
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$9,121
JanuviaSitagliptin Phosphate11$8,473
TrintellixVortioxetine Hydrobromide14$7,999
BelsomraSuvorexant12$5,084
SynthroidLevothyroxine Sodium46$3,719
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$3,029
Levothyroxine Sodium163$1,534
Losartan Potassium200$1,506
Rosuvastatin Calcium108$1,377
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$1,223
Ezetimibe49$1,149
Amlodipine Besylate199$1,067

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$106$55,83142 claims
Lilly USA, LLCMounjaro$409$48,03433 claims
Novo NordiskOzempic$800$27,83721 claims
MerckJanuvia, Belsomra$115$13,55823 claims
GSKTrelegy Ellipta$98$9,12114 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$143$7,99914 claims
AbbVieSynthroid$185$3,71946 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Marietta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →